Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
X-linked Charcot-Marie-Tooth disease type 4 is a rare, genetic, axonal, peripheral sensorimotor neuropathy characterized by an X-linked recessive inheritance pattern and the neonatal- to early childhood-onset of severe, slowly progressive, distal muscle weakness and atrophy (in particular of the peroneal group), as well as sensory impairment (with the lower extremities being more affected than the upper extremities), pes cavus, areflexia and hammertoes. Sensorineural hearing loss and cognitive impairment may also be associated. Females are asymptomatic and do not display the phenotype.
Features include always present findings: Elevated creatine kinase (muscle enzyme) (elevated circulating creatine kinase concentration), Elevated LDH (tissue damage marker) (increased circulating lactate dehydrogenase concentration), and Elevated circulating hepatic transaminase concentration; and very common findings: Sensory neuropathy, Decreased nerve conduction velocity, Areflexia, and Pes cavus and others. 27 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 9 | Sensory axonal neuropathy, Difficulty with thinking and memory (cognitive impairment), Motor axonal neuropathy |
Muscles | 4 | Distal lower limb muscle weakness, Muscle weakness, Distal muscle weakness |
Lab test results | 3 | Elevated creatine kinase (muscle enzyme) (elevated circulating creatine kinase concentration), Elevated LDH (tissue damage marker) (increased circulating lactate dehydrogenase concentration), Elevated circulating hepatic transaminase concentration |
Bones and joints | 3 | Sideways curvature of the spine (scoliosis), Excessive outward curvature of the upper spine (kyphosis), Skeletal muscle atrophy |
Ears | 2 | Hearing loss (hearing impairment), Inner ear hearing loss (sensorineural hearing impairment) |
Arms and legs | 2 | Distal lower limb muscle weakness, Distal lower limb amyotrophy |
Digestive system | 1 | Elevated circulating hepatic transaminase concentration |
AIFM1 encodes apoptosis inducing factor mitochondria associated 1 (613 aa). Functions both as NADH oxidoreductase and as regulator of apoptosis. Highest expression in Adrenal Gland (62.8 TPM) and Cells EBV-transformed lymphocytes (58.3 TPM).
Charcot-Marie-Tooth disease X-linked recessive 4 is associated with mutations in the AIFM1 gene on chromosome X.
AIFM1 is classified as a druggable target (Druggable Genome category) with score 5.2.
Genetic testing for AIFM1 is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 3 always present features, 7 very common features, 6 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for Charcot-Marie-Tooth disease X-linked recessive 4.
1 publication has been identified in PubMed for Charcot-Marie-Tooth disease X-linked recessive 4. Research spans Basic Science / Preclinical (100%).
Rahikkala E (2024). [PMID: 39305100](https://pubmed.ncbi.nlm.nih.gov/39305100/). *Molecular genetics & genomic medicine*. [Basic Science / Preclinical]
Data assembled from 6 of 12 sources · Last updated Sep 20, 2026, 6:08 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about Charcot-Marie-Tooth disease X-linked recessive 4